Dr. Luke Dreisbach
Claim this profileDesert Hematology Oncology Medical Group, Inc.
Studies Non-Small Cell Lung Cancer
Studies Prostate Cancer
7 reported clinical trials
18 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
2Prostate Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Luke Dreisbach is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting0 awards Phase 2 & 3
Fuzuloparib + AA-P
for Prostate Cancer
This trial is testing whether a combination of Fuzuloparib and AA-P is better for treating advanced prostate cancer. The treatment aims to kill cancer cells by preventing them from fixing their damaged DNA and by reducing hormone levels that help the cancer grow. The study includes patients with and without specific DNA repair deficiencies.
Recruiting1 award Phase 37 criteria
More about Luke Dreisbach
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Luke Dreisbach has experience with
- Cemiplimab
- Fianlimab
- Pemetrexed
- Nivolumab
- Docetaxel
- Placebo
Breakdown of trials Luke Dreisbach has run
Non-Small Cell Lung Cancer
Prostate Cancer
Lung Cancer
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Luke Dreisbach specialize in?
Luke Dreisbach focuses on Non-Small Cell Lung Cancer and Prostate Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Luke Dreisbach currently recruiting for clinical trials?
Yes, Luke Dreisbach is currently recruiting for 3 clinical trials in Rancho Mirage California. If you're interested in participating, you should apply.
Are there any treatments that Luke Dreisbach has studied deeply?
Yes, Luke Dreisbach has studied treatments such as Cemiplimab, Fianlimab, Pemetrexed.
What is the best way to schedule an appointment with Luke Dreisbach?
Apply for one of the trials that Luke Dreisbach is conducting.
What is the office address of Luke Dreisbach?
The office of Luke Dreisbach is located at: Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California 92270 United States. This is the address for their practice at the Desert Hematology Oncology Medical Group, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.